EMBC
Embecta Corp. Healthcare - Medical Instruments & Supplies Investor Relations →
Embecta Corp. (EMBC) closed at $10.86 as of 2026-02-02, trading 37.9% below its 200-week moving average of $17.50. This places EMBC in the extreme value zone. The stock moved further from the line this week, up from -39.7% last week. The 14-week RSI sits at 36, indicating neutral momentum.
Over the past 154 weeks of data, EMBC has crossed below its 200-week moving average 1 time. On average, these episodes lasted 150 weeks.
With a market cap of $643 million, EMBC is a small-cap stock. The company generates a free cash flow yield of 29.0%, which is notably high. The stock trades at -1.1x book value.
Share count has increased 2.5% over three years, indicating dilution.
Over the past 3.1 years, a hypothetical investment of $100 in EMBC would have grown to $38, compared to $181 for the S&P 500. EMBC has returned -26.8% annualized vs 21.3% for the index, underperforming the broader market over this period.
Free cash flow has been declining at a -22.3% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Growth of $100: EMBC vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After EMBC Crosses Below the Line?
Across 1 historical episodes, buying EMBC when it crossed below its 200-week moving average produced an average return of -51.0% after 12 months (median -51.0%), compared to +30.0% for the S&P 500 over the same periods. After 24 months, the average return was -54.0% vs +40.0% for the index.
Each line shows $100 invested at the moment EMBC crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
EMBC has crossed below its 200-week MA 1 time
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| Mar 2023 | Ongoing | 150+ | 56.4% | Ongoing | -56.9% |
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of Friday close, 2026-02-02